Caniglia EC, Zash R, Diseko M, Mabuta J, et al. Target trials of pre-conception switch from Nevirapine- or Efavirenz-based ART to dolutegravir-based ART on adverse birth and maternal outcomes. AIDS 2025 Aug 13. doi: 10.1097/QAD.0000000000004321.
PMID: 40811078